Monday Apr 7
Meda AB, Valeant Pharmaceuticals International Terminate Joint Ventures
Meda And Valeant Terminates Joint Ventures GOTEBORG, Sweden-- Regulatory News: Meda has reached an agreement with Valeant to terminate the companies' joint ventures in Canada, Mexico and Australia in the second quarter of 2014.
Trending on the Topix Network
Wed Apr 02, 2014
Valeant Pharmaceuticals Intl Receives Average Recommendation of "Buy" from Brokerages
Valeant Pharmaceuticals Intl has earned an average rating of "Buy" from the nineteen analysts that are presently covering the stock, ARN reports .
Tue Apr 01, 2014
Top Guru-Held Canadian Stocks
Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership.
Wed Mar 26, 2014
Wednesday 3/26 Insider Buying Report: SANW, VRX
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
Stocks: Insiders Buy at Regeneron, Valeant, and MDC Partners
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.
Tue Mar 25, 2014
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%
Actavis acquired the rights to Metronidazole 1.3% from Valeant Pharmaceuticals International in Bacterial vaginosis is an infection caused by an imbalance in the normal bacteria in the vagina.
Fri Mar 21, 2014
Reviewing the Top Health Care Equities -- Research on...
The gains were broad based as nine of ten sectors finished higher. The S&P 500 Health Care Sector Index finished the day 0.02% lower at 686.29, whereas, the index has advanced 0.77% in the last one month.
Thu Mar 20, 2014
Valeant Pharmaceuticals International CEO Eyes Corporate "Fat" In Push For Big Leagues
After Valeant Pharmaceuticals International Inc. bought Bausch & Lomb Inc. for $8.7 billion last year, Chief Executive Officer Mike Pearson discovered the budget for the eyecare company's communications team was 13 times the size of his own.
Wed Mar 19, 2014
Valeant Pharmaceuticals Intl Sees Large Drop in Short Interest
Valeant Pharmaceuticals Intl saw a significant decrease in short interest in the month of January.